PDF
(Download)
|
- Aloe Vera (Aloe vera, Xanthorrhoeaceae)
- Psoriasis
- Research Quality
|
Date:
04-30-2015 | HC# 041561-519
|
Re: Review Examines Outcomes and Quality of Studies in Clinical Research on Topical Treatment of Psoriasis with Aloe Vera Preparations
Miroddi M, Navarra M, Calapai F, et al. Review of clinical pharmacology of Aloe vera L. in the treatment of psoriasis. Phytother Res.
March 10, 2015; [epub ahead
of print]. doi: 10.1002/ptr.5316.
Aloe vera (Aloe vera, Xanthorrhoeaceae) is commonly
used for skin ailments and as a first aid treatment for minor burns.1
The gel from leaves has been found to contain a diverse array of bioactive phytochemicals,
including anthraquinones and phenolics. Previous work has shown aloe vera to be
an immunomodulator and to have anti-microbial, anti-inflammatory, and
antioxidant activity. Psoriasis is a chronic skin disease characterized by
changes in skin lesions, and current conventional therapies have unreliable efficacy
and may cause troublesome adverse effects. Based on its history of use in skin
problems, aloe vera may be useful in treating this condition. This review
reports on clinical studies of efficacy and safety of aloe vera treatment for
psoriasis.
The databases
CENTRAL Cochrane Library, Embase, Medline, and Web of Science were searched up
to October 2014 for clinical trials. Search terms included "aloe,"
"Aloe vera," "Aloe barbadensis," and "aloe
gel." These terms were also used in combination with "psoriasis"
or "psoriatic plaque." To gauge trial quality, the Jadad scale (a
scale ranging from 0 to 5 where the higher number indicates higher trial quality)
and the Consolidated Standards of Reporting Trials (CONSORT) Statement in
Reporting Clinical Trials of Herbal Medicine Intervention were utilized; the
latter consists of a checklist of details of botanical characterization, treatment,
and methodology that quality randomized clinical trials should include.
In total, four
clinical trials were reviewed, with three trials scoring a 4 (according to the
Jadad scale) and one trial scoring a 2. They consisted of an open-label or
double-blind design and used either a placebo or active control (specifically,
triamcinolone acetonide [TA]). For two trials, patients received both control and
aloe vera treatment and used them on one side of the body each for comparison.
In the other trials, each patient received placebo, control, or treatment only.
In three of the studies, aloe vera preparations alone were used; in the
remaining study, a combination treatment including aloe vera was used. The
primary outcomes were changes in symptoms of psoriasis and results of the
Psoriasis Area and Severity Index (PASI). This score is from 0, indicating no
disease, to 72, indicating most severe disease, and is based on the percentage
of body area affected by psoriasis.
One of the
double-blind, placebo-controlled, randomized trials reviewed here included 60
patients; equal numbers used either a cream with 0.5% aloe vera extract or
placebo cream (both creams with a mineral oil and castor [Ricinus communis, Euphorbiaceae] oil mixture) three times daily, five
days in a row each week, for four weeks total. In those using the aloe cream,
PASI score was lessened from 9.3 to 2.2, and 45% of patients in this group had
an improvement of psoriasis. There were no adverse side effects noted. [Note: There
is no mention about the significance of these results in comparison to the
placebo group.] The second study examined effects of a combination ultraviolet
treatment with aloe vera, volcanic earth, and vitamin E on 14 patients that
used treatment on one side of the body and placebo on the other, both two times
per day for six weeks. Lesion induration, or thickening, was significantly improved
at the end of the study in the treatment group with no adverse side effects. No
P value was reported.
Another study
including 41 patients tested aloe vera and placebo used twice daily for four
weeks on different sides of the body on each patient. There was one patient
dropout for reasons not specified. At the end of the study, erythema,
desquamation (redness and peeling, respectively), and infiltration were lessened
in 72.5% of those using aloe vera, but also in 82.5% of those using placebo. In
15 patients, PASI scores improved significantly more on the placebo side of the
body. In the last study reviewed, treatment with aloe vera was compared with
0.1% TA in two separate groups of patients for eight weeks. The PASI scores
were less in both groups at the end of the study; however, the authors mention
that the aloe vera treatment was "slightly" better than TA, based on
greater improvements in PASI scores and Dermatology Life Quality Index. It is
mentioned that, although considered safe overall, aloe vera has caused adverse
side effects such as urticaria, dermatitis, or allergic reaction in published
case reports.
The authors conclude that results from the
studies reviewed are conflicting. According to the Jadad scores of the included
trials, the study using a combination therapy was of lower quality than the
others. Pertinent for replicating findings, making meaningful comparisons, or
drawing conclusions, preparation details or compound profiles of the aloe vera treatments
used were not included. In summary, the studies reviewed here do not indicate that
aloe vera in general is an effective treatment for those suffering from
psoriasis. Future rigorous clinical trials are necessary.
—Amy C.
Keller, PhD
Reference
1Lewis WH, Elvin-Lewis
MPF. Medical Botany: Plants Affecting
Human Health. Hoboken, New Jersey: John Wiley & Sons, Inc.; 2003.
|